| Literature DB >> 24361515 |
Liselotte Fransson1, Victoria Rosengren1, Titu Kumar Saha1, Nina Grankvist1, Tohidul Islam1, Richard E Honkanen2, Åke Sjöholm3, Henrik Ortsäter4.
Abstract
Glucocorticoid excess is associated with glucose intolerance and diabetes. In addition to inducing insulin resistance, glucocorticoids impair β-cell function and cause β-cell apoptosis. In this study we show that dexamethasone activates mitogen-activated protein kinases (MAPKs) signaling in MIN6 β-cells, as evident by enhanced phosphorylation of p38 MAPK and c-Jun N-terminal kinase (JNK). In contrast, the integrated stress response pathway was inhibited by dexamethasone. A p38 MAPK inhibitor attenuated dexamethasone-induced apoptosis in β-cells and isolated islets and decreased glucocorticoid receptor phosphorylation at S220. In contrast, a JNK inhibitor augmented DNA fragmentation and dexamethasone-induced formation of cleaved caspase 3. We also show that inhibition of protein phosphatase 5 (PP5) augments apoptosis in dexamethasone-exposed islets and β-cells, with a concomitant activation of p38 MAPK. In conclusion, our data provide evidence that in islets and β-cells, p38 MAPK and JNK phosphorylation work in concert with PP5 to regulate the cytotoxic effects exerted by glucocorticoids.Entities:
Keywords: Apoptosis; Glucocorticoids; JNK; Pancreatic islet; Protein phosphatase 5; p38 MAPK
Mesh:
Substances:
Year: 2013 PMID: 24361515 DOI: 10.1016/j.mce.2013.12.010
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN: 0303-7207 Impact factor: 4.102